Friday, 30 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Latest announcements

Every corporate announcement our alert engine sent, newest first: orders, results, earnings calls, fund raises, board meetings and more.

11:14 IST NSE
Production StartedRamdevbaba Solvent Ltd RBS

Ramdevbaba Solvent Production Started

Ramdevbaba Solvent Limited's subsidiary, RBS Renewables Private Limited, commenced its first ethanol dispatch to Oil Marketing Companies on April 7, 2026. Factory operations at the Chandrapur unit are reported to be running smoothly. This milestone signifies the start of commercial revenue generation from the company's ethanol business segment.

11:12 IST BSE
AcquisitionCyient Ltd CYIENT

Cyient Acquisition Worth ₹790.5 Cr

Cyient Semiconductors has completed a ₹790.50 Crore ($85M) majority investment in Kinetic Technologies, a global power semiconductor firm. The acquisition adds over 100 silicon-proven IPs and immediate product scale to Cyient's semiconductor platform. This move aligns with India's Semiconductor Mission, positioning the company to address a $44 billion global market opportunity in power and compute infrastructure.

Value
₹790.5 Cr
11:11 IST BSE
Other AnnouncementKMC Speciality Hospitals (India) Ltd KMCSHIL

KMC Speciality Hospitals (India) Other Announcement

KMC Speciality Hospitals (India) Ltd submitted a confirmation certificate from its RTA, Cameo Corporate Services Limited, for the quarter ended March 31, 2026. The certificate confirms that securities received for dematerialization were processed and listed on the stock exchanges within the required 15-day timeframe.

10:48 IST BSE
Other AnnouncementChambal Fertilisers & Chemicals Ltd CHAMBLFERT

Chambal Fertilisers & Chemicals Other Announcement

Chambal Fertilisers and Chemicals Limited submitted its Regulation 74(5) compliance certificate for the quarter ended March 31, 2026. The filing, issued by KFin Technologies, confirms that securities received for dematerialisation were processed and listed within prescribed timelines. This is a routine regulatory disclosure with no immediate material financial impact.